In fact, by catalyzing histone H3 Thr11 phosphorylation in response to AR activation, PRK1 has been dubbed a “gate-keeper” of androgen-induced transcriptional activation and, therefore, of androgen-driven prostate cancer. Here, AR is linked to prostate carcinoma.